Introduction
Achalasia is a benign idiopathic disorder caused by progressive neuronal degeneration in the mesenteric plexus of Auerbach, which causing non-relaxing, hypertensive lower esophageal sphincter (LES) and aperistalsis of the esophageal body 1 . This functional damage is irreversible and the treatment of esophageal achalasia is mainly palliative. The most recognized clinical features of the disease are progressive dysphagia, regurgitation, chest pain, and weight loss . The advantage of surgical myotomy is that disruption of the muscular fibers is accomplished under direct vision. An additional procedure -anti-reflux procedure can be added during the same setting. We have done open laparotomy, then mobilization of lower oesophagus and stomach followed by a long incision at lower oesophagus (myotomy). Anterior fundoplication was done as an anti-reflux procedure. The introduction of a laparoscopic approach (minimally invasive) has regained primacy 5 .
A recent meta-analysis suggested that good clinical efficacy combined with low morbidity has established laparoscopic myotomy as a definitive, safe, and effective alternative in the treatment of achalasia. Laparoscopic myotomy is less invasive than open surgery,but is expensive and the results depend mainly on the surgeon's expertise. Nevertheless, we strongly suggest that endoscopic treatment is advisable with frequent follow-up before surgical treatment commenced³.
Conclusion
Open surgical procedure gives good result even in long term follow up. But laparoscopic myotomy is the preferred and recommended method in the management of achalasia. Laparoscopic myotomy with partial fundoplication is superior to other treatment methods because of its excellent efficacy and safety, and also prevent acid exposure in the distal esophagus. Open surgical procedure can be performed where laparoscopic facility as well as expert personal is not available.
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She was initially started with proton pump inhibitor (Pantoprazole). Nystatin suspension was added to treat the fungal esophagitis. Barium swallow x-ray of oesophagus (Fig. 2) showing bird's beak appearance, which strongly suggest that the patient is suffering from achalasia of cardia. After initial management, patient was taken for operative procedure. Laparotomy was done under general anaesthesia, stomach and oesophagus were mobilized, oesophagialmyotomy with anterior fundoplication (Heller-Dor's operation) was done. Post-operative recovery was good. The general condition of the patient was gradually improving. Follow up after one year; she was healthy, having no complication and regain about five kilogram of body weight. Discussion There are currently four modalities for the treatment of achalasia, which including pharmacological therapy, endoscopic Botulinum toxin A (Botox) injection, pneumatic dilatation and surgical myotomy 3 . Pharmacological therapy, which include isosorbitedinitrate and calcium channel blockers are generally is consideredonly in patients who are not candidate for surgery or other treatment modalities. Endoscopic pneumatic dilatation of the LES may be the most effective treatment for achalasia non-surgically. However, it can lead to LES incompetence and gastroesophageal reflux in some cases, and the most severe
